Your browser doesn't support javascript.
loading
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study.
Jin, Harry; Geiger, Caroline; Jessop, Nikki; Pedotti, Rosetta; Raposo, Catarina; Whitley, Louise; Brown, Jeffrey S; Muros-Le Rouzic, Erwan.
Afiliación
  • Jin H; TriNetX, 125 Cambridgepark Drive, Suite 500, Cambridge, MA 02140, USA.
  • Geiger C; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA.
  • Jessop N; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel 4070, Switzerland.
  • Pedotti R; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel 4070, Switzerland.
  • Raposo C; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel 4070, Switzerland.
  • Whitley L; tranScrip Partners Ltd, Regus Unit, 220 Wharfedale Road, Wokingham, UK.
  • Brown JS; TriNetX, 125 Cambridgepark Drive, Suite 500, Cambridge, MA 02140, USA; Department of Population Medicine, Harvard Medical School, 401 Park Drive, Suite 401, Boston, MA 02215, USA.
  • Muros-Le Rouzic E; F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, Basel 4070, Switzerland. Electronic address: erwan.muros@roche.com.
Mult Scler Relat Disord ; 79: 104943, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37716211

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos